Skip to Main Content

Paper Details

Genetic disruption of myostatin reduces the development of proatherogenic dyslipidemia and atherogenic lesions in Ldlr null mice.
Diabetes
47
2009
Insulin, LDL cholesterol, Ldlr, Ldlr(-/-), Mstn, Mstn(+/+), Mstn(-/-), Myostatin, VLDL, [(3)H]-2-deoxyglucose, aortic atherogenesis, aortic atheromatous lesion, aortic atheromatous lesions, atherogenesis, atherogenic lesions, atherosclerosis, cholesterol, dyslipidemia, fatty acid, fatty acids, glucose, hepatic steatosis, insulin, insulin resistance, mice, myostatin, obesity, proatherogenic, triglycerides, type 2 diabetes

Datasets

Release 1.2